Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126373
Status:
COMPLETED
Last Update Posted:
2012-01-20
First Post:
2005-08-02
Brief Title:
A Trial of Wellbutrin for Crohns Disease
Sponsor:
Altschuler Eric MD
Organization:
Altschuler Eric MD
Study Overview
Official Title:
A Randomized Controlled Trial of Wellbutrin for Crohns Disease
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators are testing the hypothesis that Wellbutrin bupropion can give a clinical remission in Crohns disease
Detailed Description:
Wellbutrin bupropion is approved for use as an antidepressant There have been some cases in which people on Wellbutrin had significant improvement clinically in their Crohns disease In this trial the hypothesis that Wellbutrin can induce clinical remission in Crohns disease will be tested The investigators will also be looking to see if Wellbutrin can lower levels of the inflammatory cytokine tumor necrosis factor-alpha TNF
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None